Advanced search
Publication Cover
Gut Microbes Volume 11, 2020 - Issue 1
Submit an article Journal homepage
3,524
Views
17
CrossRef citations to date
0
Altmetric
Research Paper/Report

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

Breanna McSweeneyDepartment of Medicine, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Jessica R. AllegrettiDivision of Gastroenterology, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USAView further author information
,
Monika FischerDivision of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USAView further author information
,
Huiping XuDepartment of Biostatistics, The Richard M. Fairbanks School of Public Health and School of Medicine, Indiana University, Indianapolis, IN, USAView further author information
,
Karen J. GoodmanDepartment of Medicine, University of Alberta, Edmonton, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0002-3790-3217View further author information
ORCID Icon,
Tanya MonaghanNIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UKView further author information
,
Carmen McLeodNottingham Synthetic Biology Research Centre, School of Life Sciences, University of Nottingham, Nottingham, UKORCID Iconhttps://orcid.org/0000-0003-2005-3778View further author information
ORCID Icon,
Benjamin H. MullishDivision of Integrative Systems Medicine and Digestive Disease, Faculty of Medicine, Imperial College London, London, UKORCID Iconhttps://orcid.org/0000-0001-6300-3100View further author information
ORCID Icon,
Elaine O. PetrofDepartment of Medicine, Queen’s University, Kingston, Ontario, CanadaView further author information
,
Emmalee L. PhelpsDivision of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USAView further author information
,
Roxana ChisDepartment of Medicine, Queen’s University, Kingston, Ontario, CanadaView further author information
,
Abby EdmisonDepartment of Medicine, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Angela JubyDepartment of Medicine, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Ralph Ennis-DavisDepartment of Medicine, Alberta Health Services, Edmonton, Alberta, CanadaView further author information
,
Brandi RoachZeidler Ledcor Center, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Karen WongZeidler Ledcor Center, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaView further author information
&
Dina KaoZeidler Ledcor Center, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6096-0586View further author information
ORCID Icon show all
Pages 51-62 | Received 01 Feb 2019, Accepted 18 Apr 2019, Published online: 23 May 2019

References

  • Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis. 2016;16(447):1–18. doi:10.1186/s12879-016-1786-6.
  • Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–498 quiz 499. doi:10.1038/ajg.2013.4.
  • Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, et al. Burden of clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834. doi:10.1056/NEJMoa1408913.
  • Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30(1):57–66. doi:10.1086/592981.
  • Rodrigues R, Barber GE, Ananthakrishnan AN. A comprehensive study of costs associated with recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol. 2017;38(2):196–202. doi:10.1017/ice.2016.246.
  • Heimann SM, Cruz Aguilar MR, Mellinghof S, Vehreschild M. Economic burden and cost-effective management of Clostridium difficile infections. Med Mal Infect. 2018;48(1):23–29. doi:10.1016/j.medmal.2017.10.010.
  • Reigadas Ramirez E, Bouza ES. Economic burden of Clostridium difficile infection in European countries. Adv Exp Med Biol. 2018;1050:1–12. doi:10.1007/978-3-319-72799-8_1.
  • McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97(7):1769–1775. doi:10.1111/j.1572-0241.2002.05839.x.
  • Jiang ZD, Ajami NJ, Petrosino JF, Jun G, Hanis CL, Shah M, Hochman L, Ankoma-Sey V, DuPont AW, Wong MC, et al. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridium difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Aliment Pharmacol Ther. 2017;45(7):899–908. doi:10.1111/apt.13969.
  • Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review. Gut Microbes. 2017;8(3):225–237. doi:10.1080/19490976.2017.1286006.
  • Gezinski LB, Karandikar S, Carter J, White M. Exploring motivations, awareness of side effects, and attitudes among potential egg donors. Health Soc Work. 2016;41(2):75–83. doi:10.1093/hsw/hlw005.
  • Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, Iqbal TH. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46(5):479–493. doi:doi:10.1111/apt.14201.
  • Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102–109.e106. doi:10.1053/j.gastro.2015.04.001.
  • Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, Lowenberg M, van Den Brink GR, Mathus-Vliegen EM, de Vos WM, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110–118.e114. doi:10.1053/j.gastro.2015.03.045.
  • Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van Den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218–1228. doi:10.1016/s0140-6736(17)30182-4.
  • Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, et al. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019 Feb;49(4);354–363. doi:10.111/apt.15116.
  • Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30(1):51–58. doi:10.1111/jgh.12727.
  • Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation the answer for irritable bowel syndrome? A single-center experience. Am J Gastroenterol. 2014;109(11):1831–1832. doi:10.1038/ajg.2014.295.
  • Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O’Sullivan JM. The new era of treatment for obesity and metabolic disorders: evidence and expectations for gut microbiome transplantation. Front Cell Infect Microbiol. 2016;6:1–15. doi:10.3389/fcimb.2016.00015.
  • Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–916.e917. doi:10.1053/j.gastro.2012.06.031.
  • Haghikia A, Jorg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43(4):817–829. doi:10.1016/j.immuni.2015.09.007.
  • Cammarota G, Pecere S, Ianiro G, Masucci L, Curro D. Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis. 2016;34(3):279–285. doi:10.1159/000443362.
  • Martin CR, Mayer EA. Gut-brain axis and behavior. Nestle Nutr Inst Workshop Ser. 2017;88:45–53. doi:10.1159/000461732.
  • Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29(1):79–84. doi:10.1097/MOG.0b013e32835a4b3e.
  • Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(10):1–16. doi:10.1186/s40168-016-0225-7.
  • Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van Den Bogaerde J, Leong RW, Connor S, Ng W, et al. Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis. 2015;21(7):1600–1606. doi:10.1097/MIB.0000000000000405.
  • Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149(1):223–237. doi:10.1053/j.gastro.2015.05.008.
  • Burns LJ, Dubois N, Smith MB, Mendolia GM, Burgess J, Edelstein C, Noh A, Alm E, Kassam Z. 499 donor recruitment and eligibility for fecal microbiota transplantation: results from an international public stool bank. Gastroenterology. 2015;148(4):S-96–S-97. doi:10.1016/S0016-5085(15)30331-0.
  • Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9(12):1044–1049. doi:10.1016/j.cgh.2011.08.014.
  • Edelstein C, Daw JR, Kassam Z. Seeking safe stool: canada needs a universal donor model. Cmaj. 2016;188(17–18):E431–E432. doi:10.1503/cmaj.150672.
  • Dubois N, Ling K, Osman M, Burns L, Mendolia G, Blackler D, Burgess J, Edelstein C, Noh A, Vo E, et al. Prospective assessment of donor eligibility for fecal microbiota transplantation at a public stool bank: results from the evaluation of 1387 candidate donors. Open Forum Infect Dis. 2015;2(suppl_1):962. doi:10.1093/ofid/ofv133.678.
  • Jorgensen SMD, Erikstrup C, Dinh KM, Lemming LE, Dahlerup JF, Hvas CL. Recruitment of feces donors among blood donors: results from an observational cohort study. Gut Microbes. 2018:1–11. doi:10.1080/19490976.2018.1458179.
  • Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor screening experience for fecal microbiota transplantation in patients with recurrent C. difficile infection. J Clin Gastroenterol. 2018;52(2):146–150. doi:10.1097/MCG.0000000000000768.
  • Allen SC, Lohani M, Hendershot KA, Deal TR, White T, Dixon MD, Pentz RD. Patient perspectives on compensation for biospecimen donation. AJOB Empir Bioeth. 2018;9(2):77–81. doi:10.1080/23294515.2018.1460633.
  • Bagot KL, Murray AL, Masser BM. How can we improve retention of the first-time donor? A systematic review of the current evidence. Transfus Med Rev. 2016;30(2):81–91. doi:10.1016/j.tmrv.2016.02.002.
  • Baseer S, Maha Ejaz S, Noori M, Faisal A. Knowledge, attitude, perceptions of university students towards blood donation: an assessment of motivation and barriers. Isra Med J. 2017;9:406–410.
  • Pennings G, de Mouzon J, Shenfield F, Ferraretti AP, Mardesic T, Ruiz A, Goossens V. Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries. Hum Reprod. 2014;29(5):1076–1089. doi:10.1093/humrep/deu048.
  • Kenney NJ, McGowan ML. Looking back: egg donors’ retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle. Fertil Steril. 2010;93(2):455–466. doi:10.1016/j.fertnstert.2008.09.081.
  • Svanberg AS, Lampic C, Gejervall AL, Gudmundsson J, Karlstrom PO, Solensten NG, Sydsjo G. Gamete donors’ motivation in a Swedish national sample: is there any ambivalence? A descriptive study. Acta Obstet Gynecol Scand. 2012;91(8):944–951. doi:10.1111/j.1600-0412.2012.01430.x.
  • Bay B, Larsen PB, Kesmodel US, Ingerslev HJ. Danish sperm donors across three decades: motivations and attitudes. Fertil Steril. 2014;101(1):252–257 e251. doi:10.1016/j.fertnstert.2013.09.013.
  • Chell K, Davison TE, Masser B, Jensen K. A systematic review of incentives in blood donation. Transfusion. 2018;58(1):242–254. doi:10.1111/trf.14387.
  • Bart T, Volken T, Fischer Y, Taleghani BM. Giving blood and enrolling on the stem cell donor registry: ranking of obstacles and motives in Switzerland. Transfus Med Hemother. 2014;41(4):264–272. doi:10.1159/000365457.
  • Charbonneau J, Cloutier MS, Carrier E. Why do blood donors lapse or reduce their donation’s frequency? Transfus Med Rev. 2016;30(1):1–5. doi:10.1016/j.tmrv.2015.12.001.
  • Purewal S, van Den Akker OB. British women’s attitudes towards oocyte donation: ethnic differences and altruism. Patient Educ Couns. 2006;64(1–3):43–49. doi:10.1016/j.pec.2005.11.007.
  • Purewal S, van Den Akker OBA. Systematic review of oocyte donation: investigating attitudes, motivations and experiences. Hum Reprod Update. 2009;15(5):499–515. doi:10.1093/humupd/dmp018.
  • Provoost V, Pennings G, Van Rompuy F. Non-donors’ attitudes towards sperm donation and their willingness to donate. J Assist Reprod Genet. 2018;35(1):107–118. doi:10.1007/s10815-017-1036-x.
  • Kent J, Fannin M, Dowling S. Gender dynamics in the donation field: human tissue donation for research, therapy and feeding. Sociol Health Illn. 2019;41(3):567–584. doi:10.1111/1467-9566.12803.
  • NHS Blood and Transplant. Supplementary data tables and figures: 2017. In. Wllington House, 133-155 Waterloo Road, London SE1 8UG: Public Health England; 2018:1–35.
  • Bani M, Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfus. 2010;8(4):278–287. doi:10.2450/2010.0156-09.
  • Bilal M, Haseeb A, Zahid I, Lashkerwala S, Saeeduddin F, Saad M, Arshad M, Moorpani M, Khan M, Tariq A, et al. Knowledge, attitudes and perceptions among non blood donor female health care professionals. Glob J Health Sci. 2015;8(4):203–211. doi:10.5539/gjhs.v8n4p203.
  • Mäkinen EI. Tuning clinical recruitment around cultural taboos in a human microbiome study. Sci Cult (Lond). 2018;27(2):1–24. doi:10.1080/09505431.2018.1508429.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.